Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021
暂无分享,去创建一个
Robin L. Jones | A. Italiano | R. Riedel | W. Tap | K. Ganjoo | S. Schuetze | P. Hohenberger | S. Kroll | P. Schöffski | T. Alcindor | G. Grignani | D. Reed | Z. Pápai | S. Attia | A. Krarup-Hansen | L. Cranmer | T. Pearce | S. Chawla | B. A. Tine | A. López-pousa